Prostate Cancer
Efficacy of taxotere, thalidomide, and prednisolone in patients with hormone-resistant metastatic prostate cancer - Abstract
January 11, 2013
The treatment of castration-resistant prostate cancer - Abstract
January 10, 2013
The change of prostate cancer treatment in Korea: 5 Year analysis of a single institution - Abstract
January 10, 2013
Autoimmune diseases and subsequent urological cancers - Abstract
January 10, 2013
Evolution of prostate cancer brachytherapy - Abstract
January 10, 2013
Analysis of the lipid profile and atherogenic risk during androgen deprivation therapy in prostate cancer patients - Abstract
January 10, 2013
The role of urine prostate cancer antigen 3 mRNA levels in the diagnosis of prostate cancer among Hong Kong Chinese patients - Abstract
January 10, 2013
Prostatic specific antigen and bone scan in the diagnosis and follow-up of prostate cancer. Can diagnostic significance of PSA be increased? - Abstract
January 10, 2013
Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study - Abstract
January 10, 2013
Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: The ProtecT study - Abstract
January 9, 2013